LAG3 and neoplasm: However, the expression levels of its receptor LAG-3 were significantly increased on tumor-infiltrating hepatic CD8+ T and NK cells from MC38 tumor–bearing mice compared with control mice (Figure 7D), suggesting that there may be an FGL1/LAG-3 interaction in the liver tumor microenvironment.